Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/17/23
End: 02/09/24
Due: 02/09/25
Phase: N/A
Priority: Normal
Start: 06/19/20
End: 02/08/22
Due: 02/08/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease | NCT05914909 | AdAlta Limited | user2@example.com | None | 2023-07-17 | 2024-02-09 | 2025-02-09 | - | - | 2025-07-14 |
| Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers | NCT04415671 | AdAlta Limited | user2@example.com | None | 2020-06-19 | 2022-02-08 | 2023-02-08 | - | - | 2025-07-14 |